Using Maurice CE-SDS in ICH Q6B based Biosimilar Comparability Exercises

Join our Technical Director of Structural Analysis Dr. Richard L. Easton as he presents data from projects where CE-SDS was used to characterize different biopharmaceuticals, such as monoclonal antibodies, heavily glycosylated species and PEGylated species. Richard describes how BioPharmaSpec scientists are using the Maurice platform to interrogate structural attributes such as heterogeneity, partial species in monoclonal antibody samples, product related impurities and comparability assessments.

This webinar will benefit scientists focused optimizing analytical strategies to accelerate biosimilar development.